Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Long-Term Investments (2020 - 2021)

Historic Long-Term Investments for Beam Therapeutics (BEAM) over the last 2 years, with Q3 2021 value amounting to $24.5 million.

  • Beam Therapeutics' Long-Term Investments changed N/A to $24.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $24.5 million, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2020, which is N/A changed from last year.
  • Per Beam Therapeutics' latest filing, its Long-Term Investments stood at $24.5 million for Q3 2021.
  • Beam Therapeutics' 5-year Long-Term Investments high stood at $29.4 million for Q2 2021, and its period low was $2.6 million during Q4 2020.